Literature DB >> 21257980

Differentiation in the momentary rating of somatic symptoms covaries with trait emotional awareness in patients at risk for sudden cardiac death.

Richard D Lane1, Cheryl Carmichael, Harry T Reis.   

Abstract

OBJECTIVES: Somatic symptom ratings covary with neuroticism. Yet, people vary from one another in their ability to report their own emotions and differentiate them from bodily sensations. We hypothesized that stressed individuals with greater emotional awareness would experience somatic symptoms in a more differentiated way independent of neuroticism.
METHODS: Over 3 days, ecological momentary assessments were completed in 161 patients (72.6% female; mean age, 35 years) with Long QT Syndrome, a genetic disorder associated with increased risk for sudden cardiac death. Patients were paged randomly ten times per day to report their momentary experience of nine somatic symptoms (e.g., headache, sore throat, tiredness) as well as other variables. We examined the intercorrelation between somatic symptom ratings, reasoning that greater intercorrelation among ratings indicated less differentiation. Subjects completed measures of neuroticism, depression, and the Levels of Emotional Awareness Scale, a trait measure of the tendency to experience emotions in a complex and differentiated way.
RESULTS: Higher Levels of Emotional Awareness Scale-Self scores were associated with greater differentiation in the momentary rating of somatic symptoms (p < .001) in men and women independently. This association did not change after removing variance due to neuroticism, depression, or symptom intensity.
CONCLUSIONS: Among individuals stressed by having a life-threatening condition, those who are more emotionally aware report somatic symptoms in a more differentiated way. These findings regarding symptoms largely unrelated to the disorder are consistent with other evidence that medically unexplained physical symptoms, which tend to be nonspecific, may be accompanied by relatively undifferentiated negative affect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257980      PMCID: PMC5215093          DOI: 10.1097/PSY.0b013e318203b86a

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  38 in total

1.  Pervasive emotion recognition deficit common to alexithymia and the repressive coping style.

Authors:  R D Lane; L Sechrest; R Riedel; D E Shapiro; A W Kaszniak
Journal:  Psychosom Med       Date:  2000 Jul-Aug       Impact factor: 4.312

2.  The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion.

Authors:  R D Lane; D M Quinlan; G E Schwartz; P A Walker; S B Zeitlin
Journal:  J Pers Assess       Date:  1990

3.  Assessing alexithymia and related emotional ability constructs using multiple methods: interrelationships among measures.

Authors:  Mark A Lumley; Britta J Gustavson; R Ty Partridge; Gisela Labouvie-Vief
Journal:  Emotion       Date:  2005-09

4.  The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity.

Authors:  R M Bagby; G J Taylor; J D Parker
Journal:  J Psychosom Res       Date:  1994-01       Impact factor: 3.006

5.  Parental representations and depression in normal young adults.

Authors:  S J Blatt; S J Wein; E Chevron; D M Quinlan
Journal:  J Abnorm Psychol       Date:  1979-08

6.  Is alexithymia a risk factor for unexplained physical symptoms in general medical outpatients?

Authors:  C G Kooiman; J H Bolk; R Brand; R W Trijsburg; H G Rooijmans
Journal:  Psychosom Med       Date:  2000 Nov-Dec       Impact factor: 4.312

7.  Theory of mind and emotional awareness deficits in patients with somatoform disorders.

Authors:  Claudia Subic-Wrana; Manfred E Beutel; Achim Knebel; Richard D Lane
Journal:  Psychosom Med       Date:  2010-03-11       Impact factor: 4.312

8.  Emotion-processing deficits in eating disorders.

Authors:  Sarah Bydlowski; Maurice Corcos; Philippe Jeammet; Sabrina Paterniti; Sylvie Berthoz; Catherine Laurier; Jean Chambry; Silla M Consoli
Journal:  Int J Eat Disord       Date:  2005-05       Impact factor: 4.861

Review 9.  Long QT syndrome.

Authors:  Ilan Goldenberg; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-06-17       Impact factor: 24.094

10.  Alexithymia does not predict the persistence of medically unexplained physical symptoms.

Authors:  Cornelis G Kooiman; Jan H Bolk; Harry G M Rooijmans; Rutger W Trijsburg
Journal:  Psychosom Med       Date:  2004 Mar-Apr       Impact factor: 4.312

View more
  5 in total

1.  Automatic emotion processing as a function of trait emotional awareness: an fMRI study.

Authors:  Vladimir Lichev; Julia Sacher; Klas Ihme; Nicole Rosenberg; Markus Quirin; Jöran Lepsien; André Pampel; Michael Rufer; Hans-Jörgen Grabe; Harald Kugel; Anette Kersting; Arno Villringer; Richard D Lane; Thomas Suslow
Journal:  Soc Cogn Affect Neurosci       Date:  2014-08-19       Impact factor: 3.436

2.  The dynamic relationship between emotional and physical states: an observational study of personal health records.

Authors:  Ye-Seul Lee; Won-Mo Jung; Hyunchul Jang; Sanghyun Kim; Sun-Yong Chung; Younbyoung Chae
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-09       Impact factor: 2.570

3.  The impact of attachment distress on affect-centered mentalization: An experimental study in psychosomatic patients and healthy adults.

Authors:  Anna S Herrmann; Manfred E Beutel; Katharina Gerzymisch; Richard D Lane; Janine Pastore-Molitor; Jörg Wiltink; Rüdiger Zwerenz; Mita Banerjee; Claudia Subic-Wrana
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

4.  Theory of Mind and Emotional Awareness in Chronic Somatoform Pain Patients.

Authors:  Matthias Zunhammer; Agnes Halski; Peter Eichhammer; Volker Busch
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

5.  Somatic symptoms evoked by exam stress in university students: the role of alexithymia, neuroticism, anxiety and depression.

Authors:  Matthias Zunhammer; Hanna Eberle; Peter Eichhammer; Volker Busch
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.